Thermo Fisher Scientific acquires developer of patterned microchip technology for liquid chromatography

Nov. 3, 2021

Thermo Fisher Scientific announced its acquisition of Belgium-based PharmaFluidics, the developer of the μPAC range of microchip-based chromatography columns.

The µPAC portfolio of columns enhance liquid chromatography (LC) performance in biomarker, proteomics and drug research and development applications, helping biotechnology and pharmaceutical companies uncover new insights and advance scientific discovery. Performance and sensitivity are improved with the μPAC chromatography columns, allowing for the identification of substantially more compounds in complex biological samples. The μPAC portfolio acquisition complements Thermo Fisher’s existing chromatography solutions to deliver extended analytical capabilities to researchers, the company said.

Visit Thermo Fisher for more news